DK2497461T4 - Pædiatriske opløsninger omfattende en betablokker - Google Patents

Pædiatriske opløsninger omfattende en betablokker Download PDF

Info

Publication number
DK2497461T4
DK2497461T4 DK12155472.9T DK12155472T DK2497461T4 DK 2497461 T4 DK2497461 T4 DK 2497461T4 DK 12155472 T DK12155472 T DK 12155472T DK 2497461 T4 DK2497461 T4 DK 2497461T4
Authority
DK
Denmark
Prior art keywords
pediatric
blocker
beta
solutions
pediatric solutions
Prior art date
Application number
DK12155472.9T
Other languages
English (en)
Other versions
DK2497461T3 (da
Inventor
Christine Chaumont
Elie Leverd
Valérie Muguet
Jean-François Cordoliani
Original Assignee
Pierre Fabre Dermatologie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40940328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2497461(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pierre Fabre Dermatologie filed Critical Pierre Fabre Dermatologie
Publication of DK2497461T3 publication Critical patent/DK2497461T3/da
Application granted granted Critical
Publication of DK2497461T4 publication Critical patent/DK2497461T4/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK12155472.9T 2009-04-21 2010-04-12 Pædiatriske opløsninger omfattende en betablokker DK2497461T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09290298A EP2246044A1 (en) 2009-04-21 2009-04-21 Paediatric solutions comprising a beta-blocker
EP10717263.7A EP2421504B2 (en) 2009-04-21 2010-04-12 Paediatric solutions comprising propranolol

Publications (2)

Publication Number Publication Date
DK2497461T3 DK2497461T3 (da) 2018-09-03
DK2497461T4 true DK2497461T4 (da) 2022-02-14

Family

ID=40940328

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12155472.9T DK2497461T4 (da) 2009-04-21 2010-04-12 Pædiatriske opløsninger omfattende en betablokker
DK10717263.7T DK2421504T4 (da) 2009-04-21 2010-04-12 Pædiatriske opløsninger omfattende propanolol

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10717263.7T DK2421504T4 (da) 2009-04-21 2010-04-12 Pædiatriske opløsninger omfattende propanolol

Country Status (32)

Country Link
US (2) US20120035270A1 (da)
EP (4) EP2246044A1 (da)
JP (1) JP5695029B2 (da)
KR (1) KR101713866B1 (da)
CN (1) CN102405041A (da)
AR (2) AR076338A1 (da)
AU (1) AU2010240551B2 (da)
BR (1) BRPI1015447B1 (da)
CA (1) CA2755175C (da)
CL (1) CL2011002634A1 (da)
CO (1) CO6410278A2 (da)
CY (2) CY1119390T1 (da)
DK (2) DK2497461T4 (da)
ES (2) ES2685178T5 (da)
GE (1) GEP20146087B (da)
HR (2) HRP20170610T4 (da)
HU (2) HUE039937T2 (da)
IL (1) IL214674A (da)
LT (2) LT2421504T (da)
MA (1) MA33003B1 (da)
MX (1) MX337463B (da)
NZ (1) NZ594592A (da)
PL (2) PL2497461T5 (da)
PT (2) PT2497461T (da)
RS (2) RS57668B2 (da)
RU (1) RU2011139233A (da)
SG (1) SG172960A1 (da)
SI (2) SI2497461T2 (da)
TN (1) TN2011000350A1 (da)
TW (1) TWI429459B (da)
UA (1) UA107570C2 (da)
WO (1) WO2010122442A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246044A1 (en) 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker
CN103501775A (zh) * 2011-03-04 2014-01-08 格吕伦塔尔有限公司 他喷他多的胃肠外给药
MX388963B (es) 2011-03-04 2025-03-20 Gruenenthal Gmbh Formulacion farmaceutica acuosa de tapentadol para administracion oral
JP2019142972A (ja) * 2011-03-04 2019-08-29 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口的投与
US9724297B2 (en) 2014-04-01 2017-08-08 Arbor Pharmaceuticals, Inc. Sotalol compositions and uses of the same
PE20171651A1 (es) 2015-03-27 2017-11-13 Gruenenthal Chemie Formulacion estable para administracion parenteral de tapentadol
EP3515412B1 (en) 2016-09-23 2025-04-23 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
CN108261411B (zh) * 2016-12-30 2021-04-30 武汉科福新药有限责任公司 用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法
CN107320467A (zh) * 2017-07-21 2017-11-07 江苏云阳集团药业有限公司 一种盐酸普萘洛尔药用组合物及其制备方法
CN108299279B (zh) * 2018-02-09 2021-03-23 北京梅尔森医药技术开发有限公司 取代芳基胺醇化合物及其制备方法和用途
US11547123B2 (en) * 2019-08-16 2023-01-10 The Folger Coffee Company Methods for reducing negative flavor attributes in coffee and compositions therefrom
US10610502B1 (en) * 2019-08-30 2020-04-07 Metacel Pharmaceuticals, LLC Oral baclofen solutions
JPWO2022071481A1 (da) 2020-09-30 2022-04-07
CN116407495A (zh) * 2023-03-09 2023-07-11 北京梅尔森医药技术开发有限公司 一种阿替洛尔口服溶液及其制备方法和应用
GB2628566A (en) 2023-03-29 2024-10-02 Novumgen Ltd An orally rapidly disintegrating tablet of propranolol and its process of preparation
WO2025068937A1 (en) 2023-09-30 2025-04-03 Liqmeds Worldwide Limited An oral liquid formulation of metoprolol
CN118021718B (zh) * 2024-04-12 2024-07-02 成都瑞尔医药科技有限公司 一种盐酸普罗帕酮注射液及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600708A (en) 1985-07-19 1986-07-15 American Home Products Corporation Propranolol hydrochloride liquid formulations
HU209251B (en) 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
EP0732064B1 (en) 1995-03-15 2001-06-06 Kao Corporation Use of a bitterness relieving agent
JPH1025253A (ja) * 1996-07-12 1998-01-27 Kao Corp 苦味低減化剤及び苦味低減化法
JPH11349492A (ja) * 1998-06-03 1999-12-21 Yamanouchi Pharmaceut Co Ltd 苦味を低減した経口用医薬組成物および苦味低減化方法
JP2001342151A (ja) * 2000-03-31 2001-12-11 Eisai Co Ltd 甘味を有する薬剤組成物
DE60213592T2 (de) * 2001-05-25 2007-08-09 Warner-Lambert Co. Llc Flüssige pharmazeutische zusammensetzung
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
WO2006093493A1 (en) * 2005-02-25 2006-09-08 Biomarin Pharmaceutical Inc. Room temperature stable aqueous liquid pharmaceutical composition
EP1888030A1 (en) * 2005-05-25 2008-02-20 Janssen Pharmaceutica N.V. Pediatric formulation of topiramate
DE102006020604A1 (de) * 2006-05-02 2007-11-08 Bayer Healthcare Ag Flüssige Arzneimittelformulierung
EP2050441A1 (en) 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
EP2268282B1 (en) * 2008-04-25 2014-10-29 Apotex Technologies Inc. Liquid formulation for deferiprone with palatable taste
EP2246044A1 (en) 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker

Also Published As

Publication number Publication date
EP3384899A1 (en) 2018-10-10
ES2623936T3 (es) 2017-07-12
WO2010122442A1 (en) 2010-10-28
PT2421504T (pt) 2017-06-16
DK2497461T3 (da) 2018-09-03
IL214674A (en) 2017-01-31
TN2011000350A1 (en) 2013-03-27
CY1120667T1 (el) 2019-12-11
MX337463B (es) 2016-03-07
HRP20181408T1 (hr) 2018-11-02
RU2011139233A (ru) 2013-05-27
PL2497461T5 (pl) 2022-06-27
EP2497461B2 (en) 2021-12-15
IL214674A0 (en) 2011-09-27
RS57668B1 (sr) 2018-11-30
CA2755175C (en) 2018-01-02
AR117621A2 (es) 2021-08-18
BRPI1015447A8 (pt) 2017-10-03
UA107570C2 (xx) 2015-01-26
MX2011010766A (es) 2011-10-21
NZ594592A (en) 2013-11-29
LT2421504T (lt) 2017-06-12
AR076338A1 (es) 2011-06-01
SI2497461T2 (sl) 2022-04-29
EP2421504A1 (en) 2012-02-29
AU2010240551B2 (en) 2015-07-16
DK2421504T3 (da) 2017-05-01
JP5695029B2 (ja) 2015-04-01
US20150087719A1 (en) 2015-03-26
BRPI1015447A2 (pt) 2016-04-19
CY1119390T1 (el) 2018-02-14
HRP20170610T1 (hr) 2017-07-28
EP2246044A1 (en) 2010-11-03
TWI429459B (zh) 2014-03-11
PT2497461T (pt) 2018-10-23
CN102405041A (zh) 2012-04-04
EP2421504B1 (en) 2017-03-08
ES2685178T5 (es) 2022-04-13
RS55862B2 (sr) 2022-12-30
SG172960A1 (en) 2011-08-29
CO6410278A2 (es) 2012-03-30
ES2685178T3 (es) 2018-10-05
EP2421504B2 (en) 2022-08-10
LT2497461T (lt) 2018-10-10
HUE039937T2 (hu) 2019-02-28
BRPI1015447B1 (pt) 2020-01-28
TW201039862A (en) 2010-11-16
SI2421504T1 (sl) 2017-06-30
CA2755175A1 (en) 2010-10-28
HRP20181408T4 (hr) 2022-03-04
DK2421504T4 (da) 2022-11-14
RS55862B1 (sr) 2017-08-31
SI2497461T1 (sl) 2018-10-30
PL2421504T3 (pl) 2017-08-31
RS57668B2 (sr) 2022-03-31
US20120035270A1 (en) 2012-02-09
HRP20170610T4 (hr) 2022-12-09
AU2010240551A1 (en) 2011-08-04
GEP20146087B (en) 2014-05-13
EP2497461A3 (en) 2014-01-01
EP2497461B1 (en) 2018-06-20
ES2623936T5 (es) 2022-11-28
KR20120015305A (ko) 2012-02-21
JP2012524773A (ja) 2012-10-18
PL2497461T3 (pl) 2018-12-31
KR101713866B1 (ko) 2017-03-09
EP2497461A2 (en) 2012-09-12
CL2011002634A1 (es) 2012-06-08
PL2421504T5 (pl) 2023-01-02
MA33003B1 (fr) 2012-01-02
HUE034581T2 (en) 2018-02-28

Similar Documents

Publication Publication Date Title
DK2497461T4 (da) Pædiatriske opløsninger omfattende en betablokker
DK2289304T3 (da) Høstmaskine
BRPI1013639A2 (pt) medicamentos antidiabéticos
FR2958801B1 (fr) Biopile a glucose
EP2515984A4 (en) INTERFACE
PL2417941T3 (pl) Urządzenie do noszenia wspomagające ruch
EP2415612A4 (en) TAPE CASSETTE
BRPI1010924A2 (pt) retração montada em pacientes
DE112010004490A5 (de) Kupplungseinrichtung
FI20105379L (fi) Liitinyksikkö
BR112012000657A2 (pt) novos azabicilohexanos
EP2619694A4 (en) DUALIZATION OF DATA MODEL
DK2429882T3 (da) Forbindelsesanordning
EP2499707A4 (en) INTERFACE
EP2378292A4 (en) Autoanalyzer
BRPI1009424A2 (pt) contador
PT2408498T (pt) Contador
EP2502865A4 (en) coil winder
FR2951075B1 (fr) Aiguille perforante
IT1394992B1 (it) Dispositivo ossigenatore
DE112010004218A5 (de) Kupplungseinrichtung
IT1396671B1 (it) Scambiatore a microcanali
DE112010002723A5 (de) Doppelkupplung
DE112010001579T8 (de) Kupplungseinrichtung
DK2210985T3 (da) Forbindelsesindretning